Trials / Terminated
TerminatedNCT03471481
Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 7 (actual)
- Sponsor
- Drexel University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention. Study is Cross Sectional in nature | No Intervention. Study is cross sectional in nature |
Timeline
- Start date
- 2015-08-10
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2018-03-20
- Last updated
- 2021-03-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03471481. Inclusion in this directory is not an endorsement.